New York State Common Retirement Fund’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
16,565
+6,300
| +61% | +$94.3K | ﹤0.01% | 2162 |
|
|
2025
Q1 | $166K | Hold |
10,265
| – | – | ﹤0.01% | 2308 |
|
|
2024
Q4 | $239K | Hold |
10,265
| – | – | ﹤0.01% | 2226 |
|
|
2024
Q3 | $302K | Sell |
10,265
-4,100
| -29% | -$121K | ﹤0.01% | 2134 |
|
|
2024
Q2 | $338K | Sell |
14,365
-305
| -2% | -$7.18K | ﹤0.01% | 2199 |
|
|
2024
Q1 | $556K | Buy |
14,670
+14,305
| +3,919% | +$542K | ﹤0.01% | 2033 |
|
|
2023
Q4 | $8K | Buy |
+365
| New | +$8K | ﹤0.01% | 3202 |
|
|
2022
Q3 | – | Sell |
-14
| Closed | – | – | 3439 |
|
|
2022
Q2 | $0 | Sell |
14
-668
| -98% | – | ﹤0.01% | 3537 |
|
|
2022
Q1 | $39K | Hold |
682
| – | – | ﹤0.01% | 3216 |
|
|
2021
Q4 | $81K | Sell |
682
-1
| -0.1% | -$119 | ﹤0.01% | 3132 |
|
|
2021
Q3 | $136K | Sell |
683
-576
| -46% | -$115K | ﹤0.01% | 3039 |
|
|
2021
Q2 | $219K | Buy |
1,259
+15
| +1% | +$2.61K | ﹤0.01% | 3012 |
|
|
2021
Q1 | $246K | Hold |
1,244
| – | – | ﹤0.01% | 2756 |
|
|
2020
Q4 | $245K | Sell |
1,244
-292
| -19% | -$57.5K | ﹤0.01% | 2667 |
|
|
2020
Q3 | $272K | Hold |
1,536
| – | – | ﹤0.01% | 2517 |
|
|
2020
Q2 | $355K | Buy |
1,536
+780
| +103% | +$180K | ﹤0.01% | 2389 |
|
|
2020
Q1 | $88K | Hold |
756
| – | – | ﹤0.01% | 2810 |
|
|
2019
Q4 | $144K | Sell |
756
-312
| -29% | -$59.4K | ﹤0.01% | 2884 |
|
|
2019
Q3 | $205K | Sell |
1,068
-4
| -0.4% | -$768 | ﹤0.01% | 2758 |
|
|
2019
Q2 | $184K | Buy |
1,072
+728
| +212% | +$125K | ﹤0.01% | 2865 |
|
|
2019
Q1 | $69K | Hold |
344
| – | – | ﹤0.01% | 3027 |
|
|
2018
Q4 | $64K | Hold |
344
| – | – | ﹤0.01% | 3060 |
|
|
2018
Q3 | $82K | Sell |
344
-380
| -52% | -$90.6K | ﹤0.01% | 3073 |
|
|
2018
Q2 | $191K | Buy |
+724
| New | +$191K | ﹤0.01% | 2895 |
|